Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy

B H Lorell1

  • 1Charles A Dana Research Institute, Boston, Massachusetts, USA.

Insights

The cardiac renin-angiotensin system plays a key role in pressure-overload hypertrophy and heart failure. Angiotensin II (Ang II) directly impairs diastolic function, but angiotensin-converting enzyme (ACE) inhibition improves it.

Area of Science:

  • Cardiology
  • Renal Physiology

Background:

  • The cardiac renin-angiotensin system (cRAS) is implicated in pressure-overload-induced cardiac hypertrophy and failure.
  • Angiotensin II (Ang II) may directly affect diastolic function in hypertrophied hearts.

Purpose of the Study:

  • To review studies on the role of cRAS in cardiac hypertrophy and failure.
  • To investigate the effects of angiotensin-converting enzyme (ACE) inhibition on cardiac function.

Main Methods:

  • Utilized the aortic banded rat model of cardiac hypertrophy.
  • Assessed intracardiac Ang II levels, diastolic function, and neurohormonal markers.
  • Evaluated the impact of acute intracardiac ACE inhibition in patients with aortic stenosis.

Main Results:

  • Intracardiac Ang I to Ang II conversion is increased in hypertrophied hearts.
  • Ang II directly impairs diastolic relaxation and tone.
  • ACE inhibition improved diastolic function in patients and reduced LV diastolic pressure in rats.
  • ACE inhibition normalized elevated noradrenaline levels and reduced cardiac dimensions.

Conclusions:

  • The cardiac renin-angiotensin system is a critical mediator of pressure-overload hypertrophy and cardiac dysfunction.
  • Targeting intracardiac ACE activity offers a therapeutic strategy for diastolic dysfunction and heart failure.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...